Two Sigma Advisers’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$3.31M Buy
1,146,924
+752,900
+191% +$2.18M 0.01% 896
2025
Q1
$847K Buy
394,024
+327,000
+488% +$703K ﹤0.01% 1544
2024
Q4
$259K Sell
67,024
-30,100
-31% -$116K ﹤0.01% 2036
2024
Q3
$636K Sell
97,124
-35,000
-26% -$229K ﹤0.01% 1605
2024
Q2
$958K Sell
132,124
-61,300
-32% -$444K ﹤0.01% 1571
2024
Q1
$1.47M Buy
193,424
+84,100
+77% +$638K ﹤0.01% 1383
2023
Q4
$497K Sell
109,324
-49,900
-31% -$227K ﹤0.01% 1926
2023
Q3
$629K Sell
159,224
-63,500
-29% -$251K ﹤0.01% 1707
2023
Q2
$697K Sell
222,724
-22,300
-9% -$69.8K ﹤0.01% 1682
2023
Q1
$1.11M Buy
245,024
+110,500
+82% +$501K ﹤0.01% 1584
2022
Q4
$556K Buy
134,524
+59,800
+80% +$247K ﹤0.01% 1840
2022
Q3
$239K Buy
+74,724
New +$239K ﹤0.01% 2147
2022
Q2
Sell
-13,998
Closed -$57K 2788
2022
Q1
$57K Sell
13,998
-14,200
-50% -$57.8K ﹤0.01% 2570
2021
Q4
$304K Sell
28,198
-4,700
-14% -$50.7K ﹤0.01% 2138
2021
Q3
$379K Buy
+32,898
New +$379K ﹤0.01% 2025
2021
Q2
Sell
-11,689
Closed -$171K 2584
2021
Q1
$171K Buy
11,689
+1,900
+19% +$27.8K ﹤0.01% 2379
2020
Q4
$210K Buy
+9,789
New +$210K ﹤0.01% 2154
2020
Q3
Sell
-13,496
Closed -$173K 2538
2020
Q2
$173K Sell
13,496
-4,362
-24% -$55.9K ﹤0.01% 2280
2020
Q1
$165K Sell
17,858
-2,025
-10% -$18.7K ﹤0.01% 2218
2019
Q4
$265K Hold
19,883
﹤0.01% 2101
2019
Q3
$176K Buy
19,883
+4,800
+32% +$42.5K ﹤0.01% 2066
2019
Q2
$215K Buy
15,083
+8,066
+115% +$115K ﹤0.01% 2111
2019
Q1
$231K Buy
7,017
+4,450
+173% +$146K ﹤0.01% 2074
2018
Q4
$152K Buy
2,567
+1,375
+115% +$81.4K ﹤0.01% 2178
2018
Q3
$167K Buy
+1,192
New +$167K ﹤0.01% 2107
2015
Q2
Sell
-458
Closed -$218K 1989
2015
Q1
$218K Buy
+458
New +$218K ﹤0.01% 1711